Caxton Associates (New York)’s Ginkgo Bioworks DNA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-59,415	Closed	-$484K	–	536
2024 Q3	$484K	Buy	+59,415	New	+$484K	0.02%	364
2024 Q2	–	Sell	-9,435	Closed	-$438K	–	504
2024 Q1	$438K	Buy	+9,435	New	+$438K	0.02%	338